-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ICIP in Skin Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ICIP in Skin Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ICIP in Skin Cancer Drug Details: iCIP is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ICIP in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ICIP in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ICIP in Solid Tumor Drug Details: iCIP is under development for...
-
Product Insights
NewAlmac Diagnostic Services Ltd Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Almac Diagnostic Services Ltd Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Almac Diagnostic Services Ltd (Almac Diagnostic Services), a subsidiary of Almac Group Ltd, is a medical diagnostic company that discovers, develops and commercializes diagnostic tests including companion diagnostics. The company provides products pipeline such as ColDx, DDRD, AADx, prostate Dx and MEK Dx, among others. It offers ColDx, a prognostic assay for stage II and III colon cancer,...
-
Company Insights
NewGenetic Analysis AS Pipeline Insight and Competitive Landscape, 2024
Empower your strategies with our Genetic Analysis AS Pipeline Insight and Competitive Landscape, 2024 report and make more profitable business decisions. Genetic Analysis AS (Genetic Analysis) is a molecular diagnostic company that mapping of microbiota by utilizing the GA-map technology to develop IVD tests in various diseases. Its products include service products and lab products. Service and lab products include dysbiosis test Lx reagent kit, Covid-19 fecal test reagent kit. It offers services include research and diagnostics, companion diagnostics, laboratory...
-
Product Insights
NewAres Genetics GmbH Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Ares Genetics GmbH Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Ares Genetics develops Artificial Intelligence informed DNA-Sequencing Tests to revolutionize Infectious Disease and Drug Resistance Testing. Their specialties include IT services, Molecular Diagnostics, Molecular Epidemiology, Biomarker Discovery & Licensing, Data Solutions, Next Generation Sequencing, Assay Development, (Pre)-Clinical Solutions, Companion Diagnostics, Outbreak Monitoring, Antimicrobial Stewardship, and Functional Analyses. The company is headquartered in Wien, Austria. GlobalData's Medical Devices company profile...
-
Product Insights
NewNucleix Ltd Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Nucleix Ltd Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Nucleix Ltd (Nucleix) manufactures, develops and markets various tests for non-invasive molecular cancer diagnostic. The company offers bladder epicheck, a test to monitor the bladder cancer. It also offers epicheck for colorectal cancer and lung cancer. Its platform also helps to grade tumors and prognostic assessment, companion diagnostics and detection of neurodegenerative diseases. The company’s biomarker panel discovery tool helps...
-
Product Insights
NewQuantuMDx Group Ltd Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our QuantuMDx Group Ltd Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. QuantuMDx Group Ltd (QuantuMDx) operates as a developer of sciences tools and diagnostics products. The company’s products include Q-POC, a handheld DNA analyzer that provides an accurate molecular diagnostic results. It develops assays for diagnosis and drug susceptibility testing of infectious diseases, and companion diagnostics assays and tumour profiling. QuantuMDx also develops technologies such as Q-PREP, Q-AMP, Q-DETECT, and...
-
Product Insights
NewCelcuity Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Celcuity Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Celcuity Inc (Celcuity) is a cellular analysis company. It develops companion diagnostic tests to identify new patient populations for targeted therapies. The company’s CELx signaling function diagnostic platform utilizes a patient’s living tumor cells to identify the specific abnormal cellular activity. It also develops CELx multi-pathway (MP) signaling function test for breast cancer which measures HER1, HER2, HER3, and c-Met...
-
Product Insights
NewPrometheus Biosciences Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Prometheus Biosciences Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Prometheus Biosciences Inc (Prometheus Biosciences) is the biotech company that discover, develops and commercializes novel therapeutic and companion diagnostic product candidates for inflammatory bowel disease (IBD). The company’s pipeline products include PRA023, an anti-TL1A mAb for the treatment of ulcerative colitis and crohn’s disease; and PR600, PR300, PR1100, PR1800 and PR2100 against inflammatory bowel disease (IBD). It utilizes Prometheus360,...